Sangamo Therapeutics
SGMO
#10574
Rank
ยฃ23.19 M
Marketcap
ยฃ0.05598
Share price
0.00%
Change (1 day)
-82.03%
Change (1 year)

Sangamo Therapeutics (SGMO) - Cash on Hand

Cash on Hand as of March 2026 : ยฃ20.86 Million

According to Sangamo Therapeutics 's latest financial reports the company has ยฃ20.86 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sangamo Therapeutics - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31ยฃ15.55 M-53.43%
2024-12-31ยฃ33.4 M-47.46%
2023-12-31ยฃ63.58 M-72.29%
2022-12-31ยฃ0.22 B-17.73%
2021-12-31ยฃ0.27 B-40.72%
2020-12-31ยฃ0.47 B70.24%
2019-12-31ยฃ0.27 B-12.31%
2018-12-31ยฃ0.31 B75.1%
2017-12-31ยฃ0.18 B55.85%
2016-12-31ยฃ0.11 B-18.09%
2015-12-31ยฃ0.14 B22.69%
2014-12-31ยฃ0.11 B104.29%
2013-12-31ยฃ56.26 M43.11%
2012-12-31ยฃ39.31 M-27.36%
2011-12-31ยฃ54.12 M38.61%
2010-12-31ยฃ39.05 M-25.6%
2009-12-31ยฃ52.49 M18.66%
2008-12-31ยฃ44.23 M8.37%
2007-12-31ยฃ40.81 M48.28%
2006-12-31ยฃ27.52 M1.1%
2005-12-31ยฃ27.22 M57.17%
2004-12-31ยฃ17.32 M-29.33%
2003-12-31ยฃ24.51 M-24.61%
2002-12-31ยฃ32.52 M-23.45%
2001-12-31ยฃ42.48 M-0.17%
2000-12-31ยฃ42.55 M804.7%
1999-12-31ยฃ4.7 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
ยฃ13.03 B 62,351.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ10.58 B 50,610.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ0.97 B 4,558.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
ยฃ3.13 B 14,914.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ2.40 B 11,423.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.40 B 25,786.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ2.71 B 12,903.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.66 B 3,068.29%๐Ÿ‡บ๐Ÿ‡ธ USA